An OHSU patient set to receive a bone marrow transplant receives news that his surgery is delayed due an influx of severely ill patients with COVID-19.

Marcus T. Altman, M.D., describes research that found a home-monitoring technology can accurately identify age-related macular degeneration, enabling early treatment that results in better visual acuity outcomes.

Eliza Bakken, M.D., discusses the risks of sending kids back to school in person and suggests the best thing to do to protect our kids is for adults to get vaccinated.

Oregon Health & Science University warned people not to use ivermectin to prevent or treat COVID. The Oregon Poison Center managed 21 ivermectin cases in August after handling just three in all of 2020, OHSU said.

“It looks like we are seeing the flattening of cases we had hoped for,” said Peter Graven, lead data scientist in OHSU’s Business Intelligence Unit.

Peter Graven, a data scientist at Oregon Health and Sciences University, has published his latest modeling that shows the trend of the virus in the state.

In response to equity concerns regarding non-binary runner registration for the Portland Marathon, an OHSU spokesperson says OHSU contacted the event organizers who quickly remedied the issue.

As Oregon surpasses 300,000 cases of COVID-19, new projections from Peter Graven, Ph.D., show continued severe strain on Oregon hospitals until mid-November.

“It looks like we are seeing the flattening of cases that we had hoped for,” said OHSU's Peter Graven, M.D. “However, we are still projecting it will be a very long time before hospitalization levels return to more manageable levels.”

“The good news is that we did peak,” said Peter Graven, M.D., with Oregon Health and Science University. “The bad news is, the model is showing that it could take until the end of October or even November until we really get down to the levels that we had prior to the surge.”